Skip to content

BIOSENSYS

Active Public limited companyfounded 2005active for 21 yearsAvenue des Etats-Unis 7, 6041 CharleroiKBO/BCE: BE 0871.249.941

Lifetime

19 annual accounts with figures on one time axis, 20 filings since 2005
peak of €426,235 in 2010
€1,909▼ 99.0%
lowest -€485,905 in 2017
-€87,062▼ €26,382
peak of €1.1m in 2020
€820,788▼ 9.6%
€1.8m▲ 31.0%
peak of 7 FTE in 2010
-not published
Board6 names since 2013
1 director
Documentsfilings and deeds
14-12-2025136 days late
2024micro format
Gross margin from €199,504 to €1,909Loss of €87,062Transfer of 400 shares from to 22-07Debts from €1.3m to €1.8mCash from €4,276 to €9,922

Key points

from the 2024 annual accounts

Losses

-€269,073 in four years
-78,9552021-42,3772022-60,6792023-87,0622024

Every financial year from 2021 to 2024 closed with a loss. 2024 was the heaviest.

Liquidity

22.73 was 0.27 in 2023

Short-term debts fell from €861,579 to €24,402.

Filings

20 annual accounts 110 days past the deadline
AprilJune31 JulyOctober2005201020152020

2025 accounts not filed: deadline was 31-07-2026.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 8,616 companies had the same profile as BIOSENSYS has now. Each dot stands for 22 companies, two years later.

94.2%
were still trading
5.2%
stopped another way
0.4%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a small loss

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 8,616 companies, not a prediction for BIOSENSYS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
  • 1,600 sharesdeed of 22-07-2024
  • 400 sharesdeed of 22-07-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0871249941
Judicial dissolution, liquidator appointed Enterprise Court of Hainaut, Charleroi division · Ghilain Melanie · judgment of 17-11-2025 · Judicial dissolution
Transfer of 400 shares from to holds 1,600 shares · holds 400 shares · General meeting of 01-07-2024 · Gazette deed
appointed as managing director holds 200 shares · General meeting of 26-09-2023 · Gazette deed
All 35 events

Comparable companies

same main activity, similar in size and age
Company
BIOSENSYS Charleroi €2.6m €1,909 31.9% -
IMMOBA Aalter €1.9m €2,499 74.6% -
MELEZES69 Brussels €1.7m €1,367 18.0% -
NOORDJOK Staden €2.4m -€56,908 45.8% -
MUSEA SCULPTA Bruges €2.7m -€44,602 -26.8% 1.6
DYCIMMO Denderleeuw €2.3m -€5,153 10.1% -
STEMATCO Maasmechelen €2.8m €3,034 30.6% -

These companies have the same main activity as BIOSENSYS: renting and operating of own or leased residential real estate, excluding social housing (NACE 68201). They are comparable in size and age: total assets between €1.7m and €2.8m, founded between 1996 and 2008.

Official details

Source: KBO
Status
Active since 17-01-2005Normal situation
Activity
Renting and operating of own or leased residential real estate, excluding social housingNACE 68201
Establishment units
2.156.193.2046041 Charleroi, since 22-09-2006
2.156.193.6975000 Namur, since 22-09-2006
Financial year end
31 December
Peppol
Reachable since 22-12-2025
Company details

Annual accounts 2024

≈ €5,100estimated
€2.6m▲ 14.6%
Filing
Filed on 14-12-2025
Financials

Insights on BIOSENSYS

BIOSENSYS files the micro format. That format states no turnover. The gross margin fell from €300,616 in 2006 to €1,909 in 2024.

The balance sheet grew most in 2020 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BIOSENSYS

What is the company number of BIOSENSYS?
The company number of BIOSENSYS is 0871.249.941. The VAT number is the same number with BE in front: BE 0871.249.941.
Where is BIOSENSYS based?
The registered office is at Avenue des Etats-Unis 7, 6041 Charleroi.Company details
What does BIOSENSYS do?
According to the KBO register, the main activity is renting and operating of own or leased residential real estate, excluding social housing (NACE 68201).
What is the legal form of BIOSENSYS?
BIOSENSYS is a public limited company (NV).
When was BIOSENSYS founded?
BIOSENSYS was founded on 17-01-2005.
Is BIOSENSYS still active?
Yes, BIOSENSYS is an active enterprise in the KBO register.
What is the turnover of BIOSENSYS?
The turnover in financial year 2024 is ≈ €5,100. This figure is estimated from the gross margin of €1,909 and 36 comparable companies (NACE 68201). It probably lies between €3,300 and €8,500. It is a rough estimate.Financials
Is BIOSENSYS profitable?
In financial year 2024, BIOSENSYS made a loss of €87,062.
Where can I find the annual accounts of BIOSENSYS?
BIOSENSYS filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2024.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.